Full Text View
Tabular View
No Study Results Posted
Related Studies
Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD)
This study is currently recruiting participants.
Verified by National Institute of Neurological Disorders and Stroke (NINDS), March 2009
First Received: March 1, 2005   Last Updated: March 31, 2009   History of Changes
Sponsors and Collaborators: Columbia University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institute of Neurological Disorders and Stroke (NINDS)
ClinicalTrials.gov Identifier: NCT00104585
  Purpose

The purpose of this study is to investigate genetic and environmental risk factors that increase susceptibility to the development of early-onset Parkinson's disease (developed at or before age 50).


Condition
Parkinson's Disease

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease
MedlinePlus related topics: Parkinson's Disease
U.S. FDA Resources
Study Type: Observational
Study Design: Family-Based, Cross-Sectional
Official Title: Genetic Epidemiology of Parkinson's Disease

Further study details as provided by National Institute of Neurological Disorders and Stroke (NINDS):

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

whole blood


Estimated Enrollment: 800
Study Start Date: July 2004
Estimated Study Completion Date: April 2009
Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
People with young onset Parkinson's disease and their family members

Detailed Description:

Parkinson's disease (PD) is a common, neurodegenerative condition. Although mostly a late-onset disorder, 10 percent of people with PD are reported to develop symptoms before the age of 50. To date, six genes have been found to be associated with PD, however the majority have been found in rare PD 'families'. Some studies have also identified a number of environmental risk factors, such as pesticide use, that appear to increase the risk of PD.

In a previous study, Dr. Karen Marder and her research team found that close family members of people with both early- and late-onset PD have a three-fold increased risk of PD compared to close family members of people without PD.

The purpose of the Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) study is to identify the genetic factors that contribute to the development of early-onset Parkinson's disease, and to understand how these genetic factors interact with other genes and the environment to cause PD.

Participation in the study involves a blood draw (to look for genetic factors associated with PD), questionnaires collecting information on family and medical history, and a neurological examination. In addition participants may be contacted in the future and asked to participate in a more detailed interview. At that time, study investigators will also ask participants for permission to contact family members to invite them to participate in the study.

This research study requires participants to sign a consent form, which states that the research is voluntary and confidential. In addition, since this is a research study, genetic results are not released to participants or their family members now or in the future.

Scientists hope this multi-center study will increase the current knowledge of PD and that the identification of factors that cause PD will lead to better diagnosis and treatment.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Young onset PD patients

Criteria

Inclusion Criteria:

  • Any person with Parkinson's disease in the United States whose symptoms began at age 50 or younger and was diagnosed by a neurologist.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00104585

Contacts
Contact: Helen Mejia-Santana, M.A. 877-305-2438 research@corepdstudy.org

Locations
United States, California
The Parkinson's Institute Recruiting
Sunnyvale, California, United States, 94089
Contact: Kathleen Comyns     408-542-5620     kcomyns@parkinsonsinstitute.org    
United States, Connecticut
The Institute for Neurodegenerative Disorders Recruiting
New Haven, Connecticut, United States, 06510
Contact: Debbie Ruotolo     203-401-4366     druotolo@mnimaging.com    
United States, Illinois
Rush University Medical Center Recruiting
Chicago, Illinois, United States, 60612
Contact: Lucia M. Blasucci     312-563-2900     Lucia_M_Blasucci@rush.edu    
Glenbrook Hospital, Evanston Recruiting
Glenview, Illinois, United States, 60026
Contact: Susan Silvio     847-657-5689     ssilvio@enh.org    
United States, Maryland
Johns Hopkins Hospital Recruiting
Baltimore, Maryland, United States, 21287
Contact: Melissa Gerstenhaber     410-614-1242     mgerste1@jhmi.edu    
United States, Minnesota
Struthers Parkinson's Center Recruiting
Golden Valley, Minnesota, United States, 55427
Contact: Patricia Ede     952-993-2245     patriciaede@parknicollet.com    
United States, New York
Columbia University Recruiting
New York, New York, United States, 10032
Contact: Helen Mejia-Santana     877-305-2438     research@corepdstudy.org    
Beth Israel Medical Center Recruiting
New York, New York, United States, 10003
Contact: Paul Soto     212-844-6053        
United States, Pennsylvania
University of Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Dana Clay     215-829-7731     cdana@mail.med.upenn.edu    
United States, Rhode Island
Neuro Health Recruiting
Warwick, Rhode Island, United States, 02886
Contact: Meg Lannon     401-921-4245     mclannon@neurohealth.info    
United States, Tennessee
University of Tennessee Health Science Center Recruiting
Memphis, Tennessee, United States, 38136
Contact: Brenda Pfeiffer     901-271-5966     bpfeiffer@utmem.edu    
United States, Wisconsin
Marshfield Clinic Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Pam Mundt     715-387-5544     mundt.pamela@mcrf.mfldclin.edu    
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Karen Marder, M.D., M.PH. Columbia University
  More Information

No publications provided

Responsible Party: Columbia University ( Karen Marder, MD, MPH, Sally Kerlin Professor of Neurology )
Study ID Numbers: R01NS036630
Study First Received: March 1, 2005
Last Updated: March 31, 2009
ClinicalTrials.gov Identifier: NCT00104585     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institute of Neurological Disorders and Stroke (NINDS):
Parkinson's disease
PD
gene
environment
early-onset Parkinson's disease

Study placed in the following topic categories:
Ganglion Cysts
Movement Disorders
Parkinson Disease
Basal Ganglia Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:
Movement Disorders
Parkinson Disease
Nervous System Diseases
Basal Ganglia Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

ClinicalTrials.gov processed this record on May 07, 2009